These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 36619836
1. Cognitive assessment of Brazilian patients with multiple sclerosis: weighing the impact of disability and depressive symptoms. Andrade PS, de Cerqueira ACR, Colodetti AC, Schmidt FDR, Barreiros JMG, Teixeira AL, de Souza LC. Dement Neuropsychol; 2022; 16(3):276-283. PubMed ID: 36619836 [Abstract] [Full Text] [Related]
7. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity. López-Góngora M, Querol L, Escartín A. BMC Neurol; 2015 Mar 22; 15():40. PubMed ID: 25886168 [Abstract] [Full Text] [Related]
12. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS. Marstrand L, Østerberg O, Walsted T, Skov AC, Schreiber KI, Sellebjerg F. Mult Scler Relat Disord; 2020 Jan 22; 37():101458. PubMed ID: 31683230 [Abstract] [Full Text] [Related]
13. The influence of depression and anxiety on cognition in people with multiple sclerosis: a cross-sectional analysis. Freedman DE, Oh J, Kiss A, Puopolo J, Wishart M, Meza C, Feinstein A. J Neurol; 2024 Aug 22; 271(8):4885-4896. PubMed ID: 38730098 [Abstract] [Full Text] [Related]
14. MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis. Fulton JC, Grossman RI, Udupa J, Mannon LJ, Grossman M, Wei L, Polansky M, Kolson DL. AJNR Am J Neuroradiol; 1999 Aug 22; 20(10):1951-5. PubMed ID: 10588124 [Abstract] [Full Text] [Related]
15. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS). Charvet LE, Beekman R, Amadiume N, Belman AL, Krupp LB. J Neurol Sci; 2014 Jun 15; 341(1-2):79-84. PubMed ID: 24792098 [Abstract] [Full Text] [Related]
16. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis. Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK. Mult Scler; 2013 Sep 15; 19(10):1290-6. PubMed ID: 23459568 [Abstract] [Full Text] [Related]
17. Cognitive and neuropsychiatric disorders among MS patients from Latin America. Vanotti S, Caceres FJ. Mult Scler J Exp Transl Clin; 2017 Sep 15; 3(3):2055217317717508. PubMed ID: 28979791 [Abstract] [Full Text] [Related]
19. Working ability in individuals with different disease courses of multiple sclerosis: Factors beyond physical impairment. Renner A, Baetge SJ, Filser M, Penner IK. Mult Scler Relat Disord; 2020 Nov 15; 46():102559. PubMed ID: 33035965 [Abstract] [Full Text] [Related]
20. Cognitive function in severe progressive multiple sclerosis. Jakimovski D, Zivadinov R, Weinstock Z, Burnham A, Wicks TR, Suchan C, Sciortino T, Schweser F, Bergsland N, Dwyer MG, Eckert SP, Young-Hong D, Weinstock-Guttman B, Benedict RHB. Brain Commun; 2024 Nov 15; 6(4):fcae226. PubMed ID: 39015768 [Abstract] [Full Text] [Related] Page: [Next] [New Search]